These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2623252)

  • 21. Comparison of the in vivo pulmonary toxicity of amiodarone and des-oxo-amiodarone in the hamster.
    Rafeiro E; Leeder RG; Brien JF; Kabalka GW; Chatla N; Massey TE
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):275-81. PubMed ID: 8048071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid.
    Wilson BD; Clarkson CE; Lippmann ML
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1110-4. PubMed ID: 2024822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous regression of amiodarone pulmonary toxicity.
    Fraioli P; Barberis M; Montemurro L
    Sarcoidosis; 1990 Mar; 7(1):58-62. PubMed ID: 2345820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fibrosing pneumopathy induced by cyclothiazide. Apropos of a case].
    Kheir A; Chabot F; Lesur O; Gerard H; Delorme N; Polu JM
    Rev Mal Respir; 1992; 9(2):208-12. PubMed ID: 1565834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of the presence of mastocytes in bronchoalveolar lavage in the diagnostic evaluation of diffuse interstitial lung diseases].
    Moisés JA; Xaubet A; Agustí C; Picado C; Marín A; Agustí-Vidal A
    Med Clin (Barc); 1989 Apr; 92(12):454-6. PubMed ID: 2739472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of lamellar body quantification in leukocytes in amiodarone toxicity].
    Vargas FS; Falzoni R; Terra Filho M; Cukier A; Carvalho-Pinto RM; Pileggi F
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):184-9. PubMed ID: 1668861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy].
    Popper H; Pongratz M
    Wien Klin Wochenschr; 1987 Dec; 99(24):848-55. PubMed ID: 3439184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary toxicity associated with the use of amiodarone].
    López AM; Sánchez C; Palazzo JP; Visconti RJ
    Medicina (B Aires); 1986; 46(4):400-6. PubMed ID: 3574102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amiodarone: a new cause of hypersensitivity pneumopathy?].
    Arlet P; Carré P; Bismuth JM; Larregain-Fournier D; Le Tallec Y
    Rev Pneumol Clin; 1984; 40(3):205-7. PubMed ID: 6463506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pneumopathy caused by amiodarone. An often unrecognized iatrogenic entity].
    Bensaid J; Guéret P; Blanc P; Doumeix JJ; Virot P; Pinaud D; Bontemps T; Vergnoux H; Leymarie JL; Melloni B
    Ann Cardiol Angeiol (Paris); 1987 Jun; 36(6):307-12. PubMed ID: 3619385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe pneumopathy and amiodarone].
    Chebat J; Caubarrère I
    Therapie; 1983; 38(1):111-2. PubMed ID: 6867993
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interstitial pneumopathies during amiodarone treatment. Determination of serum amiodarone, typing of lymphocytes from bronchiolo-alveolar lavage].
    Meurice JC; Debacque I; Boita F; Underner M; Bouquet S; Preud'Homme JL; Patte F
    Pathol Biol (Paris); 1986 Dec; 34(10):1074-80. PubMed ID: 3547263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of bronchoalveolar lavage (BAL) in various diseases of the respiratory tract].
    Lasota A; Grubek-Jaworska H; Barliński J; Droszcz W
    Pol Tyg Lek; 1988 May; 43(21):674-80. PubMed ID: 3226973
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interstitial pneumopathy in subjects treated with amiodarone].
    Dezile G; Roullier A; Arbeille-Brassart B
    Presse Med; 1983 Nov; 12(43):2747-50. PubMed ID: 6228835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of bronchoalveolar lavage in interstitial lung diseases.
    Potdar PV; Jain K; Prabhakaran L; Kamat SR
    J Assoc Physicians India; 1989 Jul; 37(7):444-7. PubMed ID: 2693446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone lung: pathologic findings in clinically toxic patients.
    Myers JL; Kennedy JI; Plumb VJ
    Hum Pathol; 1987 Apr; 18(4):349-54. PubMed ID: 3557438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse interstitial pulmonary disease during amiodarone treatment.
    Farmakis M; Litos G; Melissinos C; Vic P
    Arzneimittelforschung; 1984; 34(2):223-5. PubMed ID: 6539115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary toxicity from amiodarone.
    Stover DE
    N Y State J Med; 1991 Sep; 91(9):384-5. PubMed ID: 1945148
    [No Abstract]   [Full Text] [Related]  

  • 40. [Follow-up of blood and alveolar hyper-eosinophilia in pneumopathy induced by amiodarone].
    Lavaud F; Cossart C; Tack V; Bonnaud G
    Therapie; 1990; 45(1):49-51. PubMed ID: 2343439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.